To measure ligand binding to PPARα, TR-FRET was performed with a LanthaScreen TR-FRET PPARα competitive binding assay according to the manufacturer's instructions (Invitrogen). Briefly, a serial dilution of AM6545 and GW7647, a selective PPARα agonist, was prepared in a 384-well polypropylene assay plate. Fluormone Pan-PPAR Green, PPARα-LBD, and terbium (Tb)-labeled anti-GST Abs were then added to each sample. The assay plate was incubated for 2 h at room temperature prior to measuring the 520 nm/495 nm emission ratio of each well using an Infinite F500 microplate reader (Tecan, Männedorf, Switzerland) with instrument settings as described in the manufacturer's instructions for LanthaScreen assays.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.